Author:
Li Xiang,Yang Feili,He Na,Zhang Ming,Lv Yan,Yu Yue,Dong Qian,Hou Xiaofu,Hao Yanbing,An Zhida,Zhang Haiwen,Yang Zhen,Zhai Heiyan,Guo Dagang,Cao Zhixiang,Jiang Vernon C.,Chen Yiyou
Reference42 articles.
1. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International neuroblastoma risk group database;Bagatell;J. Clin. Oncol.,2009
2. MYCN oncoprotein targets and their therapeutic potential;Bell;Cancer Lett.,2010
3. Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter;Cheng;Int. J. Biochem. Mol. Biol.,2012
4. A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma;Cheson;Cancer,2012
5. Degradation of MYCN oncoprotein by the ubiquitin system;Ciechanover;Prog. Clin. Biol. Res.,1991
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献